Factors impacting the delivery of therapeutic levels of pyrone-based HIV protease inhibitors
Pharm Biotechnol
.
1998:11:211-32.
doi: 10.1007/0-306-47384-4_10.
Authors
G E Padbury
1
,
G L Zipp
,
F J Schwende
,
Z Zhao
,
K A Koeplinger
,
K T Chong
,
T J Raub
,
S Thaisrivongs
Affiliation
1
Pharmacia & Upjohn, Inc., Kalamazoo, Michigan 49007, USA.
PMID:
9760682
DOI:
10.1007/0-306-47384-4_10
No abstract available
Publication types
Review
MeSH terms
Animals
Drug Delivery Systems
HIV Protease Inhibitors / administration & dosage
HIV Protease Inhibitors / pharmacokinetics*
Humans
Metabolic Clearance Rate
Protein Binding
Structure-Activity Relationship
Substances
HIV Protease Inhibitors